Comments
Loading...
Elevance Health Stock Guidance | NYSE:ELV | Benzinga
Elevance Health issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/10/2025 | ELV | Elevance Health | FY | 2025 | $34.15 | $34.85 | $34.49 | — | — | — | Get Alert |
| 01/23/2025 | ELV | Elevance Health | FY | 2025 | $34.15 | $34.85 | $34.86 | — | — | — | Get Alert |
| 10/17/2024 | ELV | Elevance Health | FY | 2024 | $33.00 | $33.00 | $37.26 | — | — | — | Get Alert |
| 07/17/2024 | ELV | Elevance Health | FY | 2024 | $37.20 | — | $37.28 | — | — | — | Get Alert |
| 06/12/2024 | ELV | Elevance Health | FY | 2024 | $37.20 | — | $37.28 | — | — | — | Get Alert |
| 04/18/2024 | ELV | Elevance Health | FY | 2024 | $37.20 | — | $37.15 | — | — | — | Get Alert |
| 03/04/2024 | ELV | Elevance Health | FY | 2024 | $37.10 | — | $37.15 | — | — | — | Get Alert |
| 01/24/2024 | ELV | Elevance Health | FY | 2024 | $37.10 | — | $37.05 | — | — | — | Get Alert |
| 10/18/2023 | ELV | Elevance Health | FY | 2023 | $33.00 | — | $32.93 | — | — | — | Get Alert |
| 09/20/2023 | ELV | Elevance Health | FY | 2023 | $32.85 | — | $32.93 | — | — | — | Get Alert |
| 07/19/2023 | ELV | Elevance Health | FY | 2023 | $32.85 | — | $32.78 | — | — | — | Get Alert |
| 06/13/2023 | ELV | Elevance Health | FY | 2023 | $32.70 | — | $32.85 | — | — | — | Get Alert |
| 04/19/2023 | ELV | Elevance Health | FY | 2023 | $32.70 | — | $37.00 | — | — | — | Get Alert |
| 01/25/2023 | ELV | Elevance Health | FY | 2023 | $32.60 | — | $32.69 | $164.00B | $164.00B | $163.97B | Get Alert |
| 10/19/2022 | ELV | Elevance Health | FY | 2022 | $28.95 | — | $28.85 | — | — | — | Get Alert |
| 07/20/2022 | ELV | Elevance Health | FY | 2022 | $28.70 | — | $28.64 | — | — | — | Get Alert |
FAQ
What is the most recent guidance for Elevance Health (ELV)?
The most recent guidance for Elevance Health (ELV) was reported on March 10, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $34.15 to $34.85, compared to the estimated EPS of $34.49. Additionally, Elevance Health forecasted revenue between $0.00B and $0.00B for the quarter.
Browse guidance and forecast on all stocks.